Health News Releases

May 15, 2020 16:31

92nd Vifor Pharma Group Annual General Meeting

Regulatory News: At the 92nd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the current situation a

May 15, 2020 16:13

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting t

May 14, 2020 20:51

Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering

Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scienti

May 14, 2020 18:56

Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum

Takeda Pharmaceutical Company Limited (TOKYO: 4502) (NYSE: TAK) (“Takeda”) today announced financial results for the year ended March 31, 2020 (FY2019). As a top 10 global R&D-driven biopharmaceutical

May 14, 2020 11:39

Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide

Boehringer Ingelheim and CDR-Life today announced they have entered into a collaboration and licensing agreement to research and develop antibody fragment-based therapeutics for geographic atrophy (GA

May 14, 2020 11:29

Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum Haemorrhage in All Births

Ferring Pharmaceuticals today welcomes the Swissmedic approval of Carbetocin Ferring, a heat-stable formulation of carbetocin, for the prevention of excessive bleeding after childbirth following all b

May 14, 2020 11:06

BIO KOREA 2020 International Convention Delivers Online from May 18 to 23

The BIO KOREA Organizing Committee announced it will hold the BIO KOREA 2020 International Convention scheduled for May 18-23 as an online convention instead of an in-person event for this year. Th

May 08, 2020 17:47

European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Commission has granted a Marketing Authorization for the subcutaneous (SC) formulation of Entyvio

May 07, 2020 17:10

Herbalife Nutrition Continues Supporting Korean Diabetes Society

Herbalife Nutrition Korea, a premier global nutrition company, announced that it has entered into a collaboration agreement with the Korean Diabetes Society(KDS) for the fifth consecutive year. The

May 07, 2020 09:24

Rebiotix and Ferring Announce World’s First With Positive Preliminary Pivotal Phase 3 Data for Investigational Microbiome-based Therapy RBX2660

Today, Rebiotix and Ferring Pharmaceuticals announced positive preliminary findings from their ongoing pivotal Phase 3 trial of the investigational microbiome-based treatment, RBX2660. These prelimina

May 06, 2020 19:59

Immunomic Therapeutics Announces Appointments to its Board of Directors

Immunomic Therapeutics, Inc., (“ITI”) a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today the appointment of five new me

May 06, 2020 19:06

Invicro LLC to Establish a Repository of Medical Image Datasets for COVID-19 Research

Invicro LLC, a Konica Minolta company, is working with Microsoft to create a free repository of COVID-19 diagnostic CT and X-ray datasets to facilitate understanding and treating this global threat. T

May 06, 2020 11:49

Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery

Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two methods of intraoperativ

May 06, 2020 10:36

Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis-Dependent Patients

Regulatory News: Vifor Pharma announced that its partner, Akebia Therapeutics, Inc., today reported positive top-line results from INNO2VATE, Akebia’s global phase-III cardiovascular outcomes progr

April 29, 2020 18:02

Neuraptive Therapeutics Announces FDA Clearance of IND Application for NTX-001, a Novel Approach for the Treatment of Patients with Peripheral Nerve Injuries

Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs in the treatment of periph

April 28, 2020 14:20

Takeda Announces U.S. FDA Breakthrough Therapy Designation for Mobocertinib (TAK-788) for the Treatment of NSCLC Patients with EGFR Exon 20 Insertion Mutations

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational d

April 25, 2020 10:00

BIO KOREA 2020 to Go Fully Digital with e-Conference, Online Meeting, and Virtual Exhibition from May 18 to 23

BIO KOREA 2020 International Convention, where global bio experts correspond, is shifting to an online-only event. BIO KOREA Organizing Committee has taken its final measures to execute a full digi

April 24, 2020 17:46

Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescript

April 24, 2020 16:39

Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality in Some Regions

A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne Encephalitis Va

April 24, 2020 13:37

Eurofins Technologies’ Range of Testing Kits for Serology-based Antibody Detection by ELISA in Patients Exposed to COVID-19 now Available to Order Online by Government Approved Clinical Laboratories Globally

In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of patients

April 23, 2020 17:15

Olympus Launches EVIS X1, its Most Advanced Endoscopy System to Date

Olympus Corporation (President: Yasuo Takeuchi) today announced the launch of EVIS X1, its most advanced endoscopy system to date. The new system is to improve outcomes from disorders of the stomach,

April 22, 2020 16:40

Breakthrough in the Global Battle Against Polio: AJ Vaccines Granted WHO Prequalification for New Polio Vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a si

April 22, 2020 13:35

Evaluate BETADINE® Antiseptic Products’ Effectiveness Against SARS-CoV-2

Mundipharma today announced that it will embark on an ambitious series of studies both in vitro and in vivo to evaluate the effectiveness of its BETADINE® antiseptic products against the novel coronav

April 21, 2020 18:10

Boehringer Ingelheim’s Aservo® EquiHaler® wins Red Dot for outstanding design quality

Boehringer Ingelheim is proud to announce that its Aservo® EquiHaler® received a Red Dot Award for product design. Aservo® EquiHaler® is an inhalant therapy licensed for use in horses with severe equi

April 21, 2020 16:36

European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Boehringer Ingelheim today announced that the European Commission has approved nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults.[2] The appro

News by Region

News by Industry